| Name | Orniplabin |
|---|
| Description | Orniplabin (SMTP-7) is a low-molecular-weight compound that enhances plasminogen–fibrin binding, urokinase-catalyzed activation of plasminogen, and urokinase and plasminogen-mediated fibrin degradation. Orniplabin shows potential thrombolytic and anti-inflammatory effects. Orniplabin inhibits ROS[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C51H68N2O10 |
|---|---|
| Molecular Weight | 869.09 |